
Overview
Dr. Jean Hoffman-Censits is a genitourinary cancer specialist in Baltimore, caring for patients with urothelial cancers of the bladder and upper tract. She serves as co-leader of the Women’s Bladder Cancer Program in the Greenberg Bladder Cancer Institute at the Johns Hopkins University School of Medicine. Dr. Hoffman-Censits received her undergraduate degree in neuroscience from Trinity College. She earned her M.D. degree from the Sidney Kimmel Medical College of Thomas Jefferson University. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in hematology and oncology at Temple University Medical Center. She joined the Johns Hopkins faculty in 2018. Dr. Hoffman-Censits's research interests focus on urothelial cancers. Her clinical research has helped identify urothelial cancer sub-types and establish new treatments for bladder and upper tract urothelial cancers. She is a member of the American Medical Association, the American Society of Clinical Oncology, the American Urological Association and the Society for Immunotherapy of Cancer.
Dr. Hoffman-Censits is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Bladder Reconstruction.
Dr. Hoffman-Censits is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 109 peer reviewed articles and participating in 11 clinical trials. Dr. Hoffman-Censits is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
601 North Caroline Street, Floor 4, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
11 Clinical Trials
Stoler Outpatient Cancer Clinic
Taofeek Owonikoko is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Owonikoko is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Owonikoko is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Dr. Matthias Holdhoff is a medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a professor of oncology, neurology and neurological surgery at Johns Hopkins University School of Medicine. Dr. Holdhoff’s expertise is in primary brain cancers and central nervous system lymphomas. He earned his medical degree from Freie Universität Berlin, received his doctorate degree at Charité University Medicine Berlin. Dr. Holdhoff completed residency training in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in medical oncology at Johns Hopkins Hospital with research training at the Ludwig Center for Cancer Genetics and Therapeutics (Kinzler-Vogelstein lab). As a clinical investigator in neuro-oncology, his research is focused on novel trials and translational biomarker studies in malignant gliomas and primary central nervous system lymphomas. He has led and contributed to numerous clinical trials, publications and presentations. Dr. Holdhoff serves as the director of the solid tumor inpatient service at the Sidney Kimmel Comprehensive Cancer Center. He is passionately involved in mentoring and teaching of fellows, residents and students. He is the director of the UCNS-certified neuro-oncology fellowship program at Johns Hopkins, and he is a teaching attending physician for the Osler internal medicine residency program. Dr. Holdhoff is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, and Brain Tumor. Dr. Holdhoff is board certified in American Board Of Internal Medicine. Dr. Holdhoff is currently accepting new patients.
Sidney Kimmel Comprehensive Cancer Center
Dr. Nina Wagner-Johnston is Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University. Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri. Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy. Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine. She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee. Dr. Wagner-Johnston is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Wagner-Johnston is currently accepting new patients.
Frequently Asked Questions about Dr. Jeannie H. Hoffman-Censits
How do I make an appointment with Dr. Jeannie H. Hoffman-Censits?
You can book an appointment with Dr. Jeannie H. Hoffman-Censits by calling their office at 410-955-6100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jeannie H. Hoffman-Censits a top-rated expert for Urothelial Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeannie H. Hoffman-Censits is classified as an Elite expert for Urothelial Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jeannie H. Hoffman-Censits specialize in?
While Dr. Jeannie H. Hoffman-Censits is a Oncology, they have specific expertise in Urothelial Cancer, Bladder Cancer, and Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Jeannie H. Hoffman-Censits participate in research or clinical trials?
Yes. Dr. Jeannie H. Hoffman-Censits has published 109 articles and abstracts on conditions like Urothelial Cancer. You can view a list of Dr. Jeannie H. Hoffman-Censits's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jeannie H. Hoffman-Censits accept my insurance?
Dr. Jeannie H. Hoffman-Censits accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-955-6100 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bladder CancerDr. Hoffman-Censits isElite. Learn about Bladder Cancer.
- Muscle Invasive Bladder CancerDr. Hoffman-Censits isElite. Learn about Muscle Invasive Bladder Cancer.
- Upper Tract Urothelial Carcinoma (UTUC)Dr. Hoffman-Censits isElite. Learn about Upper Tract Urothelial Carcinoma (UTUC).
- Urothelial CancerDr. Hoffman-Censits isElite. Learn about Urothelial Cancer.
- Distinguished
- Non-Muscle Invasive Bladder CancerDr. Hoffman-Censits isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- Advanced
- Chromophobe Renal Cell CarcinomaDr. Hoffman-Censits isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Hoffman-Censits isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Hoffman-Censits isAdvanced. Learn about Familial Wilms Tumor 2.
- Prostate CancerDr. Hoffman-Censits isAdvanced. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Dr. Hoffman-Censits isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Wilms TumorDr. Hoffman-Censits isAdvanced. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Hoffman-Censits isAdvanced. Learn about WT1-Related Wilms Tumor Syndromes.
- Experienced
- Adult Soft Tissue SarcomaDr. Hoffman-Censits isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Hoffman-Censits isExperienced. Learn about Agranulocytosis.
- Anal CancerDr. Hoffman-Censits isExperienced. Learn about Anal Cancer.
- Bladder ReconstructionDr. Hoffman-Censits isExperienced. Learn about Bladder Reconstruction.
- EndoscopyDr. Hoffman-Censits isExperienced. Learn about Endoscopy.
- Familial Prostate CancerDr. Hoffman-Censits isExperienced. Learn about Familial Prostate Cancer.
- Heart TumorDr. Hoffman-Censits isExperienced. Learn about Heart Tumor.
- Metastatic Brain TumorDr. Hoffman-Censits isExperienced. Learn about Metastatic Brain Tumor.
- NephrectomyDr. Hoffman-Censits isExperienced. Learn about Nephrectomy.
- Neuroendocrine TumorDr. Hoffman-Censits isExperienced. Learn about Neuroendocrine Tumor.
- Penile CancerDr. Hoffman-Censits isExperienced. Learn about Penile Cancer.
- Posterior Fossa TumorDr. Hoffman-Censits isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Hoffman-Censits isExperienced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Teratoma of the MediastinumDr. Hoffman-Censits isExperienced. Learn about Teratoma of the Mediastinum.
- Testicular CancerDr. Hoffman-Censits isExperienced. Learn about Testicular Cancer.

